Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inside Clinica No 1054

This article was originally published in Clinica

Executive Summary

Globalisation of the industry has its share of proponents and detractors, but no area is immune from its effects, especially the more mature markets of the world. Even the largely self-contained Japanese market is belatedly having to open its eyes and react to the effects on its home market of the sharp international business growth ethics that have long been the staple diet of the western world. The government is telling local medical device companies to get more competitive: to shape up or be shipped out from their own domestic market. A rude awakening for the local industry, at a time when its healthcare funding and regulatory sectors are on the threshold of major overhaul (pp 11-13).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061897

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel